financetom
Business
financetom
/
Business
/
BRIEF-Arctos Partners In Advanced Talks To Buy Majority Stake In Hayfin Capital, Deal Values Hayfin At $1.3 Bln - FT
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Arctos Partners In Advanced Talks To Buy Majority Stake In Hayfin Capital, Deal Values Hayfin At $1.3 Bln - FT
Jul 26, 2024 9:50 AM

July 26 (Reuters) -

* ARCTOS PARTNERS IN ADVANCED TALKS TO BUY MAJORITY STAKE IN

HAYFIN CAPITAL - FT

* ARCTOS PARTNERS DEAL VALUES HAYFIN AT $1.3 BILLION - FT

Source text: https://tinyurl.com/6yezwd4t

Further company coverage: [ ]

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Don't Expect Higher Bid for Canadian Western Bank, Raymond James Says
Don't Expect Higher Bid for Canadian Western Bank, Raymond James Says
Jun 13, 2024
10:42 AM EDT, 06/13/2024 (MT Newswires) -- Investors should not expect a higher bid for Canadian Western Bank ( CWESF ) than National Bank of Canada's ( NTIOF ) $5 Billion, or $52.24 per share, Raymond James said. CWB's announcement that it has agreed to be acquired by NA was probably a surprise to the street, analyst Stephen Boland said...
What's Going On With Home Furnishing Brand Lovesac Shares After Q1 Earnings?
What's Going On With Home Furnishing Brand Lovesac Shares After Q1 Earnings?
Jun 13, 2024
The Lovesac Company ( LOVE ) shares are trading higher after the company reported first-quarter results. The company reported a quarterly loss per share of $0.83, narrower than the analyst consensus loss estimate of $0.96. Lovesac’s sales totaled $132.64 million, beating the street view of $128.07 million. Net sales decreased 6.1% year over year, primarily due to a 14.8% decrease...
Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity
Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity
Jun 13, 2024
10:38 AM EDT, 06/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Thursday that the US Food and Drug Administration granted pediatric exclusivity for Nucynta and Nucynta ER, extending the exclusivity period for the Nucynta franchise by six months. The exclusivity of the Nucynta franchise has been extended to Jan. 3, 2027 while that of Nucynta ER will end...
Transcontinental Secures Approval for Normal Course Issuer Bid
Transcontinental Secures Approval for Normal Course Issuer Bid
Jun 13, 2024
10:40 AM EDT, 06/13/2024 (MT Newswires) -- Transcontinental (TCL-A.TO, TCL-B.TO) said on Thursday that it secured approval for a normal course issuer bid that allows it to buy for cancellation up to 3.7 million of its Class A subordinate voting shares and up to 668,241 of its Class B shares on the open market between June 17, 2024, and June...
Copyright 2023-2026 - www.financetom.com All Rights Reserved